93 related articles for article (PubMed ID: 11574978)
1. Amelioration of experimental colitis by thalidomide.
Kenet G; Wardi J; Avni Y; Aeed H; Shirin H; Zaidel L; Hershkoviz R; Bruck R
Isr Med Assoc J; 2001 Sep; 3(9):644-8. PubMed ID: 11574978
[TBL] [Abstract][Full Text] [Related]
2. Thalidomide treatment reduces colon injury induced by experimental colitis.
Mazzon E; Muià C; Di Paola R; Genovese T; De Sarro A; Cuzzocrea S
Shock; 2005 Jun; 23(6):556-64. PubMed ID: 15897810
[TBL] [Abstract][Full Text] [Related]
3. [Study the effect and mechanism of thalidomide in model of inflammatory bowed disease].
Wang X; Ouyang Q
Sichuan Da Xue Xue Bao Yi Xue Ban; 2005 Jul; 36(4):548-51. PubMed ID: 16078585
[TBL] [Abstract][Full Text] [Related]
4. Effect of different doses of thalidomide in experimentally induced inflammatory bowel disease in rats.
Prakash O; Medhi B; Saikia UN; Pandhi P
Basic Clin Pharmacol Toxicol; 2008 Jul; 103(1):9-16. PubMed ID: 18598295
[TBL] [Abstract][Full Text] [Related]
5. Intestinal anti-inflammatory activity of combined quercitrin and dietary olive oil supplemented with fish oil, rich in EPA and DHA (n-3) polyunsaturated fatty acids, in rats with DSS-induced colitis.
Camuesco D; Comalada M; Concha A; Nieto A; Sierra S; Xaus J; Zarzuelo A; Gálvez J
Clin Nutr; 2006 Jun; 25(3):466-76. PubMed ID: 16698151
[TBL] [Abstract][Full Text] [Related]
6. Sex steroid regulation of macrophage migration inhibitory factor in normal and inflamed colon in the female rat.
Houdeau E; Moriez R; Leveque M; Salvador-Cartier C; Waget A; Leng L; Bueno L; Bucala R; Fioramonti J
Gastroenterology; 2007 Mar; 132(3):982-93. PubMed ID: 17324399
[TBL] [Abstract][Full Text] [Related]
7. Effects of statins on experimental colitis in normocholesterolemic rats.
Jahovic N; Gedik N; Ercan F; Sirvanci S; Yüksel M; Sener G; Alican I
Scand J Gastroenterol; 2006 Aug; 41(8):954-62. PubMed ID: 16803694
[TBL] [Abstract][Full Text] [Related]
8. A protective effect of the synthetic coumarine derivative Cloricromene against DNB-colitis in the rat.
Fries W; Mazzon E; Sturiale S; Giofré MR; Lo Presti MA; Cuzzocrea S; Campo GM; Caputi AP; Longo G; Sturniolo GC
Life Sci; 2004 Apr; 74(22):2749-56. PubMed ID: 15043989
[TBL] [Abstract][Full Text] [Related]
9. Rosuvastatin, a new HMG-CoA reductase inhibitor, reduces the colonic inflammatory response in dextran sulfate sodium-induced colitis in mice.
Naito Y; Katada K; Takagi T; Tsuboi H; Isozaki Y; Handa O; Kokura S; Yoshida N; Ichikawa H; Yoshikawa T
Int J Mol Med; 2006 Jun; 17(6):997-1004. PubMed ID: 16685407
[TBL] [Abstract][Full Text] [Related]
10. Effect of combination of thalidomide and sulfasalazine in experimentally induced inflammatory bowel disease in rats.
Prakash O; Medhi B; Saikia UN; Pandhi P
Indian J Exp Biol; 2011 Sep; 49(9):672-8. PubMed ID: 21941940
[TBL] [Abstract][Full Text] [Related]
11. Therapeutic and prophylactic thalidomide in TNBS-induced colitis: synergistic effects on TNF-alpha, IL-12 and VEGF production.
Carvalho AT; Souza H; Carneiro AJ; Castelo-Branco M; Madi K; Schanaider A; Silv F; Pereira Junior FA; Pereira MG; Tortori C; Dines I; Carvalho J; Rocha E; Elia C
World J Gastroenterol; 2007 Apr; 13(15):2166-73. PubMed ID: 17465495
[TBL] [Abstract][Full Text] [Related]
12. Epigallocatechin-3-gallate ameliorates rats colitis induced by acetic acid.
Ran ZH; Chen C; Xiao SD
Biomed Pharmacother; 2008 Mar; 62(3):189-96. PubMed ID: 18325726
[TBL] [Abstract][Full Text] [Related]
13. Protection from DNBS-induced colitis by the tachykinin NK(1) receptor antagonist SR140333 in rats.
Ursino MG; Vasina V; De Ponti F
Eur J Pharmacol; 2009 Jan; 603(1-3):133-7. PubMed ID: 19103194
[TBL] [Abstract][Full Text] [Related]
14. Thalidomide treatment reduces the alteration of paracellular barrier function in mice ileum during experimental colitis.
Mazzon E; Cuzzocrea S
Shock; 2006 May; 25(5):515-21. PubMed ID: 16680017
[TBL] [Abstract][Full Text] [Related]
15. Anti-tryptase treatment using nafamostat mesilate has a therapeutic effect on experimental colitis.
Isozaki Y; Yoshida N; Kuroda M; Handa O; Takagi T; Kokura S; Ichikawa H; Naito Y; Okanoue T; Yoshikawa T
Scand J Gastroenterol; 2006 Aug; 41(8):944-53. PubMed ID: 16803693
[TBL] [Abstract][Full Text] [Related]
16. Protective effect of thalidomide on endotoxin-induced liver injury.
Enomoto N; Takei Y; Hirose M; Kitamura T; Ikejima K; Sato N
Alcohol Clin Exp Res; 2003 Aug; 27(8 Suppl):2S-6S. PubMed ID: 12960498
[TBL] [Abstract][Full Text] [Related]
17. Amelioration of experimental colitis by Copaxone is associated with class-II-restricted CD4 immune blocking.
Gur C; Karussis D; Golden E; Doron S; Ilan Y; Safadi R
Clin Immunol; 2006; 118(2-3):307-16. PubMed ID: 16290121
[TBL] [Abstract][Full Text] [Related]
18. Changtai granule, a traditional Chinese drug, protects hapten-induced colitis by attenuating inflammatory and immune dysfunctions.
Liu BG; Jia XM; Cao YY; Chen SH; Gao PH; Wang Y; Jiang YY; Cao YB
J Ethnopharmacol; 2008 Jan; 115(1):1-8. PubMed ID: 17964746
[TBL] [Abstract][Full Text] [Related]
19. Selective inhibition of phosphodiesterase-4 ameliorates chronic colitis and prevents intestinal fibrosis.
Videla S; Vilaseca J; Medina C; Mourelle M; Guarner F; Salas A; Malagelada JR
J Pharmacol Exp Ther; 2006 Feb; 316(2):940-5. PubMed ID: 16254133
[TBL] [Abstract][Full Text] [Related]
20. Effects of thalidomide in experimental models of post-endoscopic retrograde cholangiopancreatography pancreatitis.
Xiong GS; Wu SM; Wang ZH; Mo JZ; Xiao SD
J Gastroenterol Hepatol; 2007 Mar; 22(3):371-6. PubMed ID: 17295769
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
